Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTTP8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,237
Award facts
- Contract value 100% obligated
- $11,236.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Stelara 45 mg/0.5 mL syringes with a ceiling value of $11,236.74. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical and medical supply needs across multiple therapeutic domains, ranging from specialty medications and vaccines to medical devices. This delivery order for Stelara, a specialty immunosuppressant medication, exemplifies the company's role in supporting the Defense Health Agency and broader Department of Defense healthcare operations through flexible contracting vehicles that ensure reliable access to essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FTTP8?
SPE2DB25FTTP8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FTTP8 worth?
The government has obligated $11,237 on SPE2DB25FTTP8.
Is contract SPE2DB25FTTP8 an order under another contract?
Yes. SPE2DB25FTTP8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTTP8 competed?
The extent of competition for SPE2DB25FTTP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award